Verition Fund Management’s IGM Biosciences IGMS Stock Holding History

Verition Fund Management’s Portfolio IGMS Stock Details IGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-48,962	Closed	-$54.8K	–	3875
2025 Q2	$54.8K	Sell	48,962 -70,106	-59%	-$85.6K	﹤0.01%	3526
2025 Q1	$137K	Buy	+119,068	New	+$221K	﹤0.01%	3121
2024 Q3	–	Sell	-26,120	Closed	-$179K	–	3345
2024 Q2	$179K	Buy	+26,120	New	+$224K	﹤0.01%	2628
2023 Q3	–	Sell	-17,306	Closed	-$160K	–	2493
2023 Q2	$160K	Buy	+17,306	New	+$194K	﹤0.01%	1907
2021 Q2	–	Sell	-3,902	Closed	-$299K	–	2007
2021 Q1	$299K	Buy	+3,902	New	+$355K	﹤0.01%	1127

Other funds holding IGMS

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Verition Fund Management's IGMS Position: Q3 2025 in Review

Verition Fund Management sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 48,962 shares — an estimated $54.8K sold.

Verition Fund Management first reported a position in IGMS in Q1 2021 and held it in 5 quarters. The position peaked at $299K in Q1 2021. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.

Verition Fund Management reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
Verition Fund Management sold 48,962 IGM Biosciences shares in Q3 2025, an estimated $54.8K.
Verition Fund Management first reported a position in IGM Biosciences in Q1 2021 and held it in 5 quarters.
Verition Fund Management's IGM Biosciences position peaked at $299K in Q1 2021.
1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.

Based on Verition Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.